Debt decreased 41.6%
Debt changed -41.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$4.4B→$2.5B4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →MKSI financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income increased 85.9%
Operating income changed +85.9% from the comparable as-filed period.
$135.0M→$251.0M3 prior comparisons
Inventory increased 12.5%
Inventory changed +12.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$918.0M→$1.0B4 prior comparisons
Operating margin moved 624 bp higher
Operating margin changed +624 basis points from the comparable as-filed period.
13.87%→20.11%3 prior comparisons
Net income increased 182.3%
Net income changed +182.3% from the comparable as-filed period.
$62.0M→$175.0M2 prior comparisons
Revenue increased 28.3%
Revenue changed +28.3% from the comparable as-filed period.
$973.0M→$1.2B3 prior comparisons
Gross profit increased 31.3%
Gross profit changed +31.3% from the comparable as-filed period.
$453.0M→$595.0M3 prior comparisons
Inventory / revenue moved 1157 bp lower
Inventory / revenue changed -1157 basis points from the comparable as-filed period.
94.35%→82.77%3 prior comparisons
Gross margin moved 112 bp higher
Gross margin changed +112 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
46.56%→47.68%3 prior comparisons
Selling, general & administrative increased 14.3%
Selling, general & administrative changed +14.3% from the comparable as-filed period.
$175.0M→$200.0M3 prior comparisons
Stock-based compensation increased 25.0%
Stock-based compensation changed +25.0% from the comparable as-filed period.
$12.0M→$15.0M3 prior comparisons
Cash & equivalents decreased 8.8%
Cash & equivalents changed -8.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$498.0M→$454.0M4 prior comparisons
SBC / revenue moved 3 bp lower
SBC / revenue changed -3 basis points from the comparable as-filed period.
1.23%→1.20%3 prior comparisons
Research & development unchangedd 0.0%
Research & development changed +0.0% from the comparable as-filed period.
$76.0M→$76.0M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.